%0 Journal Article
%T Place of Benign Nephroangiosclerosis among the Causes of Chronic End-Stage Renal Disease in Conakry
%A Kadiatou Mamadou Bobo Barry
%A Amadou Yaya Diallo
%A Mamadou Saliou Bald&#233
%A Alpha Boubacar Bah
%A Mamadou Malal Diallo
%A Mamadou Mouctar Diallo
%A Abdou Niang
%A Alpha Oumar Bah
%J Open Journal of Nephrology
%P 120-127
%@ 2164-2869
%D 2025
%I Scientific Research Publishing
%R 10.4236/ojneph.2025.151011
%X <b>I</b><b>ntroduction: </b>The aim of this study was to identify the place of benign nephroangiosclerosis among the causes of end-stage chronic renal failure in the Nephrology Department of the Donka National Hospital. <b>Methodology: </b>This was a retrospective study from July 1, 2016, to June 30, 2020, of hypertensive patients at least 3 years old with glomerular filtration rate &lt; 15 ml/mn/1.73 m<sup>2</sup>, proteinuria less than or equal to 1 g/24 h, LVH and/or Kirkendall stage I or II hypertensive retinopathy without other associated nephropathies. <b>Results:</b> During our study period, benign nephroangiosclerosis ranked second among the presumed causes of CKD, with a prevalence of 28% (57 patients). In this series, the mean age was 48.5 years, with 32 men and 25 women, giving a sex ratio of 1.3. Other etiologies were 40% chronic glomerulonephritis, 13% diabetic nephropathy, 7% vascular and indeterminate nephropathy each, 4% chronic tubulointerstitial nephropathy and 1% polycystic kidney disease. Hypertension was WHO grade III in 20 patients (35%) and less than 6 years old in 36 patients (63%). We found a statistical association between the onset of NASB and the duration of hypertension. We recorded 81% clinical improvement in this series. <b>Conclusion: </b>Prevention, screening and treatment of high blood pressure would help reduce hypertensive nephropathy in Africa and more particularly in Guinea.
%K Hypertension
%K End Stage Renal Disease
%K Conakry
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=141484